This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Fabrus, Inc.. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Cornelia Bentley: Innovator in Therapeutic Antibodies
Introduction
Cornelia Bentley is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of therapeutic agents, particularly through her work on anti-DLL4 antibodies. Her innovative approach addresses diseases and disorders associated with DLL4, showcasing her commitment to advancing medical science.
Latest Patents
Cornelia Bentley holds a patent for "Anti-DLL4 antibodies and uses thereof." This patent outlines the development of anti-DLL4 antibodies and their application as therapeutic agents. The patent emphasizes the potential of these antibodies in treating various diseases linked to DLL4, highlighting her role in pioneering new treatment options.
Career Highlights
Bentley is associated with Fabrus, Inc., where she continues to push the boundaries of research and innovation. Her work at Fabrus, Inc. reflects her dedication to improving healthcare through scientific advancements. With her expertise, she has positioned herself as a key player in the biotechnology sector.
Collaborations
Cornelia Bentley collaborates with notable colleagues, including Vaughn V. Smider and Helen Hongyuan Mao. These partnerships enhance her research efforts and contribute to the development of groundbreaking therapeutic solutions.
Conclusion
Cornelia Bentley's contributions to the field of therapeutic antibodies exemplify her innovative spirit and dedication to improving health outcomes. Her work continues to inspire advancements in medical research and treatment methodologies.